Development of [(18)F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide

Expression of programmed cell death ligand 1 (PD-L1) within tumors is an important biomarker for guiding immune checkpoint therapies; however, immunohistochemistry-based methods of detection fail to provide a comprehensive picture of PD-L1 levels in an entire patient. To facilitate quantification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesniak, Wojciech G., Mease, Ronnie C., Chatterjee, Samit, Kumar, Dhiraj, Lisok, Ala, Wharram, Bryan, Kalagadda, Venkateswara Rao, Emens, Leisha A., Pomper, Martin G., Nimmagadda, Sridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563393/
https://www.ncbi.nlm.nih.gov/pubmed/31187691
http://dx.doi.org/10.1177/1536012119852189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563393/
https://www.ncbi.nlm.nih.gov/pubmed/31187691
http://dx.doi.org/10.1177/1536012119852189

Ejemplares similares